India Moves Forward In Policy To Lower Cost Of Pharmaceuticals...

NEWS & GOSSIP Medicine shops across the country will remain shut on Friday to protest the new National Pharmaceutical Pricing Policy (NPPP)which will bring 348 essential drugs under the price control regime. The chemists argue that they cannot bear ...

Related to : Dr Reddys Laboratories Ltd Dr Reddys Laboratories Ltd BSE 17 May 13 | 12:00 AM 2077.65 -38 (-1.8%) NSE 17 May 13 | 12:00 AM 2078.30 -40.65 (-1.92%) Hyderabad-based pharmaceutical major Dr Reddy's Laboratories Limited has welcomed ...

Shares of drug makers fell on Monday, after the government notified a new pricing policy designed to cap the prices of a greater number of formulations. The BSE's healthcare index fell 1.8 per cent, against the Sensex's 0.3 per cent fall, as ...

Drug price regulator National Pharmaceutical Pricing Authority has denied a price rise for some imported products of Sanofi, Novartis, and Allergan.In a meeting earlier this month, the regulator rejected price revision applications for Sanofi’s monocomponent insulin Lantus, Novartis’ Vitalux Plus TR tablets and Allergan India’s Pred Forte, an official said. “We have retained the existing prices of these imported products because these companies could not justify a ...

KARACHI, May 5: A meeting of the Senate's National Regulations Services (NRS) policy board committee is scheduled for Tuesday to finalise the pricing formula for drugs, which could reduce the prices of 75 per cent drugs in the country, said Senator ...

The National List of Essential Medicines will, under the new pricing policy, ostensibly make 348 essential medicines cheaper by about two to 43 per cent. The value erosion, according to IMS Health, which provides information on the healthcare ...

Research and Markets has announced the addition of the "South Korea Pharmaceutical Market Outlook 2013" report to its offerings. In a release, Research and Markets noted that report highlights include: South Korea Pharmaceutical Market Expected to ...

If the recently notified Drugs (Price Control) Order, 2013 spells good news for patients, it certainly causes worry lines for pharma companies, who say their profitability and margins will be affected in the immediate term. As per the order, prices ...

MUMBAI: The new drug price control policy that has recently been notified is likely to be a boon for consumers as it will put an end to the "arbitrary" pricing regime and bring down medicine prices, say pharma sector players. "We welcome this move ...